ALGONQUIN PWR & UTILITY - AQNCN 8.5321 07/01/2079 (AQNB) Fundamental Analysis & Valuation

NYSE:AQNB • US0158578080

26.1 USD
+0.1 (+0.38%)
Last: Mar 11, 2026, 03:59 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This AQNB fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

Overall AQNB gets a fundamental rating of 3 out of 10. We evaluated AQNB against 26 industry peers in the Multi-Utilities industry. The financial health of AQNB is average, but there are quite some concerns on its profitability. AQNB does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

3

1. AQNB Profitability Analysis

1.1 Basic Checks

  • AQNB had positive earnings in the past year.
  • In the past year AQNB had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: AQNB reported negative net income in multiple years.
  • AQNB had a positive operating cash flow in 4 of the past 5 years.
AQNB Yearly Net Income VS EBIT VS OCF VS FCFAQNB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

1.2 Ratios

  • The Return On Assets of AQNB (-0.27%) is worse than 96.15% of its industry peers.
  • The Return On Equity of AQNB (-0.80%) is worse than 96.15% of its industry peers.
  • AQNB has a Return On Invested Capital of 3.16%. This is amonst the worse of the industry: AQNB underperforms 88.46% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for AQNB is in line with the industry average of 3.74%.
  • The 3 year average ROIC (2.36%) for AQNB is below the current ROIC(3.16%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -0.27%
ROE -0.8%
ROIC 3.16%
ROA(3y)-3.11%
ROA(5y)-0.39%
ROE(3y)-11.12%
ROE(5y)-2.83%
ROIC(3y)2.36%
ROIC(5y)2.31%
AQNB Yearly ROA, ROE, ROICAQNB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

  • AQNB has a Operating Margin (21.55%) which is in line with its industry peers.
  • In the last couple of years the Operating Margin of AQNB has declined.
  • With a decent Gross Margin value of 73.94%, AQNB is doing good in the industry, outperforming 73.08% of the companies in the same industry.
  • In the last couple of years the Gross Margin of AQNB has remained more or less at the same level.
Industry RankSector Rank
OM 21.55%
PM (TTM) N/A
GM 73.94%
OM growth 3Y3.93%
OM growth 5Y-3.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.98%
GM growth 5Y0.16%
AQNB Yearly Profit, Operating, Gross MarginsAQNB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. AQNB Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AQNB is destroying value.
  • AQNB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
AQNB Yearly Shares OutstandingAQNB Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
AQNB Yearly Total Debt VS Total AssetsAQNB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

  • AQNB has an Altman-Z score of 1.33. This is a bad value and indicates that AQNB is not financially healthy and even has some risk of bankruptcy.
  • AQNB's Altman-Z score of 1.33 is amongst the best of the industry. AQNB outperforms 96.15% of its industry peers.
  • AQNB has a Debt/Equity ratio of 1.33. This is a high value indicating a heavy dependency on external financing.
  • Looking at the Debt to Equity ratio, with a value of 1.33, AQNB is in the better half of the industry, outperforming 69.23% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.33
Debt/FCF N/A
Altman-Z 1.33
ROIC/WACC0.45
WACC7.06%
AQNB Yearly LT Debt VS Equity VS FCFAQNB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

  • A Current Ratio of 1.23 indicates that AQNB should not have too much problems paying its short term obligations.
  • The Current ratio of AQNB (1.23) is better than 84.62% of its industry peers.
  • AQNB has a Quick Ratio of 1.03. This is a normal value and indicates that AQNB is financially healthy and should not expect problems in meeting its short term obligations.
  • AQNB has a Quick ratio of 1.03. This is amongst the best in the industry. AQNB outperforms 84.62% of its industry peers.
Industry RankSector Rank
Current Ratio 1.23
Quick Ratio 1.03
AQNB Yearly Current Assets VS Current LiabilitesAQNB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. AQNB Growth Analysis

3.1 Past

  • AQNB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -10.81%.
  • The earnings per share for AQNB have been decreasing by -12.41% on average. This is quite bad
EPS 1Y (TTM)-10.81%
EPS 3Y-22.17%
EPS 5Y-12.41%
EPS Q2Q%0%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%7.85%

3.2 Future

  • AQNB is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.59% yearly.
  • Based on estimates for the next years, AQNB will show a small growth in Revenue. The Revenue will grow by 6.69% on average per year.
EPS Next Y10.95%
EPS Next 2Y16.42%
EPS Next 3Y9.59%
EPS Next 5YN/A
Revenue Next Year3.84%
Revenue Next 2Y4.3%
Revenue Next 3Y6.69%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
AQNB Yearly Revenue VS EstimatesAQNB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B 2.5B
AQNB Yearly EPS VS EstimatesAQNB Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.2 0.4 0.6

More info and screens

Find the best growth stocksShow best growing peers

0

4. AQNB Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 79.09, which means the current valuation is very expensive for AQNB.
  • AQNB's Price/Earnings ratio is rather expensive when compared to the industry. AQNB is more expensive than 96.15% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of AQNB to the average of the S&P500 Index (26.25), we can say AQNB is valued expensively.
  • A Price/Forward Earnings ratio of 71.29 indicates a quite expensive valuation of AQNB.
  • AQNB's Price/Forward Earnings ratio is rather expensive when compared to the industry. AQNB is more expensive than 96.15% of the companies in the same industry.
  • AQNB's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 24.39.
Industry RankSector Rank
PE 79.09
Fwd PE 71.29
AQNB Price Earnings VS Forward Price EarningsAQNB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, AQNB is valued more expensive than 96.15% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 28.91
AQNB Per share dataAQNB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates AQNB does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)7.22
PEG (5Y)N/A
EPS Next 2Y16.42%
EPS Next 3Y9.59%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. AQNB Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 4.33%, AQNB is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 4.01, AQNB pays a bit more dividend than its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.82, AQNB pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.33%

5.2 History

  • The dividend of AQNB has a limited annual growth rate of 0.06%.
  • AQNB has been paying a dividend for over 5 years, so it has already some track record.
  • AQNB has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)0.06%
Div Incr Years1
Div Non Decr Years4
AQNB Yearly Dividends per shareAQNB Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

  • The earnings of AQNB are negative and hence is the payout ratio. AQNB will probably not be able to sustain this dividend level.
  • The dividend of AQNB is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-569.86%
EPS Next 2Y16.42%
EPS Next 3Y9.59%
AQNB Yearly Income VS Free CF VS DividendAQNB Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

More info and screens

Find the best dividend stocksShow peers with best dividend

AQNB Fundamentals: All Metrics, Ratios and Statistics

26.1

+0.1 (+0.38%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryMulti-Utilities
Earnings (Last)03-06
Earnings (Next)05-07
Inst Owners74.49%
Inst Owner ChangeN/A
Ins Owners0.03%
Ins Owner ChangeN/A
Market Cap20.05B
Revenue(TTM)N/A
Net Income(TTM)-37.22M
Analysts71.67
Price Target19.17 (-26.55%)
Short Float %0%
Short Ratio0.09
Dividend
Industry RankSector Rank
Dividend Yield 4.33%
Yearly Dividend0.41
Dividend Growth(5Y)0.06%
DP-569.86%
Div Incr Years1
Div Non Decr Years4
Ex-Date03-13
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)17.46%
Min EPS beat(2)-0.69%
Max EPS beat(2)35.61%
EPS beat(4)2
Avg EPS beat(4)12.84%
Min EPS beat(4)-25.74%
Max EPS beat(4)42.17%
EPS beat(8)4
Avg EPS beat(8)5.61%
EPS beat(12)5
Avg EPS beat(12)1.98%
EPS beat(16)6
Avg EPS beat(16)-0.66%
Revenue beat(2)1
Avg Revenue beat(2)-0.52%
Min Revenue beat(2)-1.85%
Max Revenue beat(2)0.82%
Revenue beat(4)2
Avg Revenue beat(4)-0.08%
Min Revenue beat(4)-4.61%
Max Revenue beat(4)5.31%
Revenue beat(8)3
Avg Revenue beat(8)-1.75%
Revenue beat(12)6
Avg Revenue beat(12)-0.49%
Revenue beat(16)9
Avg Revenue beat(16)0.59%
PT rev (1m)-6.46%
PT rev (3m)-13.09%
EPS NQ rev (1m)-1.58%
EPS NQ rev (3m)-16.95%
EPS NY rev (1m)-0.83%
EPS NY rev (3m)-0.83%
Revenue NQ rev (1m)-2.06%
Revenue NQ rev (3m)-2.06%
Revenue NY rev (1m)-0.29%
Revenue NY rev (3m)-0.29%
Valuation
Industry RankSector Rank
PE 79.09
Fwd PE 71.29
P/S 8.4
P/FCF N/A
P/OCF 43.05
P/B 4.32
P/tB 6.15
EV/EBITDA 28.91
EPS(TTM)0.33
EY1.26%
EPS(NY)0.37
Fwd EY1.4%
FCF(TTM)-0.47
FCFYN/A
OCF(TTM)0.61
OCFY2.32%
SpS3.11
BVpS6.04
TBVpS4.24
PEG (NY)7.22
PEG (5Y)N/A
Graham Number6.7
Profitability
Industry RankSector Rank
ROA -0.27%
ROE -0.8%
ROCE 4%
ROIC 3.16%
ROICexc 3.18%
ROICexgc 3.56%
OM 21.55%
PM (TTM) N/A
GM 73.94%
FCFM N/A
ROA(3y)-3.11%
ROA(5y)-0.39%
ROE(3y)-11.12%
ROE(5y)-2.83%
ROIC(3y)2.36%
ROIC(5y)2.31%
ROICexc(3y)2.37%
ROICexc(5y)2.33%
ROICexgc(3y)2.6%
ROICexgc(5y)2.56%
ROCE(3y)2.99%
ROCE(5y)2.93%
ROICexgc growth 3Y4.3%
ROICexgc growth 5Y-5.03%
ROICexc growth 3Y4.14%
ROICexc growth 5Y-4.63%
OM growth 3Y3.93%
OM growth 5Y-3.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.98%
GM growth 5Y0.16%
F-Score4
Asset Turnover0.17
Health
Industry RankSector Rank
Debt/Equity 1.33
Debt/FCF N/A
Debt/EBITDA 6.76
Cap/Depr 208.02%
Cap/Sales 34.55%
Interest Coverage 1.49
Cash Conversion 51.11%
Profit Quality N/A
Current Ratio 1.23
Quick Ratio 1.03
Altman-Z 1.33
F-Score4
WACC7.06%
ROIC/WACC0.45
Cap/Depr(3y)213.94%
Cap/Depr(5y)245.17%
Cap/Sales(3y)39.89%
Cap/Sales(5y)45.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-10.81%
EPS 3Y-22.17%
EPS 5Y-12.41%
EPS Q2Q%0%
EPS Next Y10.95%
EPS Next 2Y16.42%
EPS Next 3Y9.59%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%7.85%
Revenue Next Year3.84%
Revenue Next 2Y4.3%
Revenue Next 3Y6.69%
Revenue Next 5YN/A
EBIT growth 1Y-15.87%
EBIT growth 3Y4.45%
EBIT growth 5Y4.06%
EBIT Next Year45.9%
EBIT Next 3Y20.8%
EBIT Next 5YN/A
FCF growth 1Y-47.31%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-27.45%
OCF growth 3Y45.17%
OCF growth 5Y-4.65%

ALGONQUIN PWR & UTILITY - AQNCN 8.5321 07/01/2079 / AQNB FAQ

Can you provide the ChartMill fundamental rating for ALGONQUIN PWR & UTILITY - AQNCN 8.5321 07/01/2079?

ChartMill assigns a fundamental rating of 3 / 10 to AQNB.


What is the valuation status of ALGONQUIN PWR & UTILITY - AQNCN 8.5321 07/01/2079 (AQNB) stock?

ChartMill assigns a valuation rating of 0 / 10 to ALGONQUIN PWR & UTILITY - AQNCN 8.5321 07/01/2079 (AQNB). This can be considered as Overvalued.


How profitable is ALGONQUIN PWR & UTILITY - AQNCN 8.5321 07/01/2079 (AQNB) stock?

ALGONQUIN PWR & UTILITY - AQNCN 8.5321 07/01/2079 (AQNB) has a profitability rating of 3 / 10.


How financially healthy is ALGONQUIN PWR & UTILITY - AQNCN 8.5321 07/01/2079?

The financial health rating of ALGONQUIN PWR & UTILITY - AQNCN 8.5321 07/01/2079 (AQNB) is 4 / 10.


Can you provide the dividend sustainability for AQNB stock?

The dividend rating of ALGONQUIN PWR & UTILITY - AQNCN 8.5321 07/01/2079 (AQNB) is 6 / 10 and the dividend payout ratio is -569.86%.